Sanofi plans to buy more shares in Regeneron

02/12/2013 | Reuters

Sanofi plans to increase its stake in longtime drug development partner Regeneron Pharmaceuticals by purchasing shares on the open market. Sanofi holds a 16.7% stake in Regeneron. An agreement gives Sanofi the right to boost its stake in Regeneron to up to 30%. The two companies are jointly developing drugs for rheumatoid arthritis and cholesterol.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC